Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non-Current Assets (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Other Non-Current Assets data on record, last reported at $1.1 million in Q3 2025.

  • For Q3 2025, Other Non-Current Assets rose 0.67% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $1.1 million, up 0.67%, while the annual FY2024 figure was $1.0 million, 26.91% up from the prior year.
  • Other Non-Current Assets reached $1.1 million in Q3 2025 per COLL's latest filing, down from $3.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $3.8 million in Q2 2025 and bottomed at $740000.0 in Q3 2023.
  • Average Other Non-Current Assets over 5 years is $1.9 million, with a median of $2.5 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: plummeted 70.95% in 2023, then soared 348.14% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $2.5 million in 2021, then changed by 0.0% to $2.5 million in 2022, then crashed by 67.61% to $825000.0 in 2023, then increased by 26.91% to $1.0 million in 2024, then grew by 0.67% to $1.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $1.1 million in Q3 2025, $3.8 million in Q2 2025, and $1.0 million in Q1 2025.